Award recordCONTRACT

BIOMERIEUX INC

PIID 36C25719F0227· VHA· 257-NETWORK CONTRACT OFFICE 17 (36C257)· 6630 · CHEMICAL ANALYSIS INSTRUMENTS· FY2019· $835,671 net obligations· UEI HCNVCMEG9NL6· UT

Description

DE-OBLIGATION OF EXCESS FUNDS - CTX VITEK

Base award description: IGF::OT::IGF CTX VITEK BLOOD CULTURE TESTING

First action · last action
2019-03-29 · 2024-10-24
Transactions
12
First transaction's obligation
$450,087
Base + all options value (sum of deltas)
$835,671
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
3
SDVOSB flag on record
No
Parent IDV
GS07F9525S
NAICS
334516 · ANALYTICAL LABORATORY INSTRUMENT MANUFACTURING

Modification chain · 12 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$900,330$0Base award · 2019-03-29 · this action $450,087 · running total $450,087Modification P00001 · 2020-01-09 · this action $130,509 · running total $580,596Modification P00002 · 2020-12-09 · this action -$21,618 · running total $558,977Modification P00003 · 2021-01-07 · this action $137,509 · running total $696,486Modification P00004 · 2021-10-06 · this action -$33,483 · running total $663,004Modification P00006 · 2022-02-08 · this action $130,509 · running total $793,512Modification P00007 · 2022-08-17 · this action -$44,191 · running total $749,321Modification P00008 · 2023-01-09 · this action $137,509 · running total $886,830Modification P00009 · 2023-05-25 · this action $4,500 · running total $891,330Modification P00011 · 2023-11-21 · this action $9,000 · running total $900,330Modification P00010 · 2023-12-12 · this action -$42,680 · running total $857,650Modification P00012 · 2024-10-24 · this action -$21,979 · running total $835,671
  • Base2019-03-29+$450,087= $450,087
  • Mod P000012020-01-09+$130,509= $580,596
  • Mod P000022020-12-09-$21,618= $558,977
  • Mod P000032021-01-07+$137,509= $696,486
  • Mod P000042021-10-06-$33,483= $663,004
  • Mod P000062022-02-08+$130,509= $793,512
  • Mod P000072022-08-17-$44,191= $749,321
  • Mod P000082023-01-09+$137,509= $886,830
  • Mod P000092023-05-25+$4,500= $891,330
  • Mod P000112023-11-21+$9,000= $900,330
  • Mod P000102023-12-12-$42,680= $857,650
  • Mod P000122024-10-24-$21,979= $835,671
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2019-03-29+$450,087$450,087IGF::OT::IGF CTX VITEK BLOOD CULTURE TESTING
Mod P00001· EXERCISE AN OPTION2020-01-09+$130,509$580,596CTX VITEK BLOOD CULTURE TESTING
Mod P00002· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2020-12-09−$21,618$558,977CTX VITEK BLOOD CULTURE TESTING
Mod P00003· EXERCISE AN OPTION2021-01-07+$137,509$696,486CTX VITEK BLOOD CULTURE TESTING
Mod P00004· CHANGE ORDER2021-10-06−$33,483$663,004CTX VITEK BLOOD CULTURE TESTING
Mod P00006· EXERCISE AN OPTION2022-02-08+$130,509$793,512CTX VITEK BLOOD CULTURE TESTING
Mod P00007· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2022-08-17−$44,191$749,321CTX VITEK BLOOD CULTURE TESTING
Mod P00008· EXERCISE AN OPTION2023-01-09+$137,509$886,830CTX VITEK BLOOD CULTURE TESTING
Mod P00009· FUNDING ONLY ACTION2023-05-25+$4,500$891,330CTX VITEK BLOOD CULTURE TESTING
Mod P00011· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2023-11-21+$9,000$900,330DE-OBLIGATION OF EXCESS FUNDS
Mod P00010· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2023-12-12−$42,680$857,650DE-OBLIGATION OF EXCESS FUNDS - CTX VITEK
Mod P00012· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2024-10-24−$21,979$835,671DE-OBLIGATION OF EXCESS FUNDS - CTX VITEK

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI HCNVCMEG9NL6)

AwardOffice · PSC / listingNet obligationsFY
36C25926F0276NETWORK CONTRACT OFFICE 19 (36C259) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES$60,940FY2026
36C25726N0441257-NETWORK CONTRACT OFFICE 17 (36C257) · 6632 · ANALYSIS INSTRUMENTS, MEDICAL LABORATORY USE$122,631FY2026
36C25726D0091257-NETWORK CONTRACT OFFICE 17 (36C257) · 6632 · ANALYSIS INSTRUMENTS, MEDICAL LABORATORY USE$0FY2026
36C26226N0903262-NETWORK CONTRACT OFFICE 22 (36C262) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$67,946FY2026
36C24926N0666249-NETWORK CONTRACT OFFICE 9 (36C249) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$982,841FY2026
36C24126N0842241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$310,739FY2026

Other recipients under 6630 from 257-NETWORK CONTRACT OFFICE 17 (36C257) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C25726N0289SYSMEX AMERICA, INC257-NETWORK CONTRACT OFFICE 17 (36C257)$22,918FY2026
36C25726N0427GOVERNMENT SCIENTIFIC SOURCE INC257-NETWORK CONTRACT OFFICE 17 (36C257)$118,366FY2026
36C25726N0320DIAGNOSTICA STAGO INC257-NETWORK CONTRACT OFFICE 17 (36C257)$122,245FY2026
36C25726N0302QUIDELORTHO SALES COMPANY, LLC257-NETWORK CONTRACT OFFICE 17 (36C257)$46,304FY2026
36C25726N0198SYSMEX AMERICA, INC257-NETWORK CONTRACT OFFICE 17 (36C257)$244,360FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C25719F0227_3600_GS07F9525S_4730 · retrieved 2026-09-26.